A structure-based drug design approach for the identification of antiviral compounds targeting the chikungunya virus RdRp protein
There are an estimated 3 million Chikungunya virus (CHIKV) infections per year, but no vaccines or specific pharmaceutical treatments are available. RNA-dependent RNA polymerase (RdRp) of CHIKV, encoded by nonstructural protein 4 (nsP4), was targeted to identify potential antiviral compounds in this...
Main Authors: | Md. Hridoy Ahmed, Gagandeep Singh, Melvin Castrosanto, Alomgir Hossain, Md. Morshedul Islam Rifat, Sadia Hosna Rima, Vandana Gupta, Rajesh K. Kesharwani, Mariusz Jaremko, Abdul-Hamid Emwas, Prawez Alam, Faizul Azam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Chemical Physics Impact |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266702242300289X |
Similar Items
-
In silico characterization of aryl benzoyl hydrazide derivatives as potential inhibitors of RdRp enzyme of H5N1 influenza virus
by: Abhishek Ghosh, et al.
Published: (2022-09-01) -
Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017–2019
by: Thanh Vu Nguyen, et al.
Published: (2023-10-01) -
Protein Modelling Insight to the Poor Sensitivity of Chikungunya Diagnostics on Indonesia’s Chikungunya Virus
by: Bevi Lidya, et al.
Published: (2023-10-01) -
Chikungunya Virus Infection in Blood Donors and Patients During Outbreak, Mandalay, Myanmar, 2019
by: Aung Kyaw Kyaw, et al.
Published: (2020-11-01) -
Burden of Chikungunya Virus Infection during an Outbreak in Myanmar
by: Mya Myat Ngwe Tun, et al.
Published: (2023-08-01)